Blagosklonov A S, Nalivaĭko E S, Bykov G A, Kaminka T Ia, Khalilov E M
Kardiologiia. 1986 Oct;26(10):35-8.
Eighty-three patients were treated with hemosorption and essential phospholipids for coronary heart disease (CHD) and followed up for 3-5 years. The new approach to the treatment of CHD involves simultaneous removal of cholesterol-rich atherogenic lipoproteins by hemosorption and administration of essential phospholipids to increase cholesterol withdrawal from the cells. This combined treatment of coronary patients is shown to normalize cholesterol metabolism, improve microcirculation, increase stress tolerance and bring about an obvious clinical remission. The good clinical effect is corroborated by the results of bicycle ergometry and data on lipid spectrum, cholesterol metabolism, microcirculation and radio-isotope studies.
83例冠心病患者接受了血液吸附和必需磷脂治疗，并随访3至5年。冠心病治疗的新方法包括通过血液吸附同时去除富含胆固醇的致动脉粥样硬化脂蛋白，并给予必需磷脂以增加细胞内胆固醇的排出。结果显示，这种对冠心病患者的联合治疗可使胆固醇代谢正常化，改善微循环，提高应激耐受性，并带来明显的临床缓解。自行车测力计测试结果以及血脂谱、胆固醇代谢、微循环和放射性同位素研究的数据证实了良好的临床效果。
